β-lactamase substrates and methods of their use for the diagnosis of tuberculosis

US9677112B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9677112-B2
Application numberUS-201314401775-A
CountryUS
Kind codeB2
Filing dateMay 15, 2013
Priority dateMay 15, 2012
Publication dateJun 13, 2017
Grant dateJun 13, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

β-Lactamase substrates and methods for using the substrates to detect β-lactamase diagnose tuberculosis.

First claim

Opening claim text (preview).

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A compound having the formula: or an ester or a salt thereof, wherein A is selected from the group consisting of: (a) substituted and unsubstituted C6-C10 aryl; and (b) substituted and unsubstituted C3-C7 heteroaryl; R 1 is selected from the group consisting of: (a) methoxy; and (b) ethoxy; R 2 is selected from the group consisting of hydrogen, C1-C3 alkyl, C1-C3 alkyl substituted with one or more halogens, and substituted piperazine; X is O or S; R a , R b , R c , and R d are independently selected from the group consisting of hydrogen, halogen, nitro, C1-C3 alkyl, and C1-C3 alkyl substituted with one or more halogens; Z is a moiety that provides a fluorescent, luminescent, or colorimetric signal when released from the compound; and n is 0 or 1. 2. The compound of claim 1 , wherein A is phenyl. 3. The compound of claim 1 , wherein R 1 is methoxy. 4. The compound of claim 1 , wherein X is O. 5. The compound of claim 1 , wherein n is 0. 6. The compound of claim 1 , wherein n is 1. 7. The compound of claim 1 , wherein Z is a fluorescent moiety. 8. The compound of claim 1 , wherein Z is a fluorescent phenolic dye moiety. 9. The compound of claim 1 , wherein Z is selected from the group consisting of a courmarin moiety, a xanthene moiety, a resorufin moiety, a cyanine moiety, a difluoroboradiazaindacene moiety, a bimane moiety, an acridine moiety, an isoindole moiety, a dansyl moiety, an aminophthalic hydrazide moiety, an aminophthalimide moiety, an aminonaphthalimide moiety, a quinine moiety, a dicyanovinyl moiety, a tricyanovinyl moiety, an indolaniline moiety, an indamine moiety, and derivatives thereof. 10. The compound of claim 1 , wherein Z is a xanthene moiety selected from the group consisting of a fluorescein moiety, a rhodol moiety, a rhodamine moiety, and derivatives thereof. 11. The compound of claim 1 , wherein Z is 12. The compound of claim 1 , wherein Z is wherein R′ is hydrogen or aryl. 13. The compound of claim 12 , wherein R′ is phenyl or substituted phenyl. 14. The compound of claim 1 , wherein Z is 15. A compound of claim 1 having the formula: or an ester or a salt thereof, wherein R 1 is methoxy. 16. A method for detecting beta-lactamase in a sample, comprising: (a) contacting a sample with a compound of claim 1 ; and (b) measuring an optical signal generated from contacting the sample with the compound. 17. A method for diagnosing tuberculosis, comprising: (a) contacting a sample with a compound of claim 1 ; and (b) measuring an optical signal generated from contacting the sample with the compound. 18. The method of claim 17 , wherein the sample is sputum, pleural fluid, spinal fluid, blood, urine, saliva, stool, tissue biopsies, tissue homogenates, directly in live animals or human patients, or a sample obtained by swabbing an area of interest on a subject. 19. The method of claim 17 , wherein the sample comprises a pathogenic bacterial species selected from Bacteroides, Clostridium, Streptococcus, Staphylococcus, Pseudomonas, Haemophilus, Legionella, Mycobacterium, Escherichia, Salmonella, Shigella , or Listeria. 20. The method of claim 17 , wherein measuring an optical signal comprises measuring fluorescence emission intensity. 21. The method of claim 17 , wherein measuring an optical signal comprises measuring absorbance intensity. 22. The method of claim 17 , wherein measuring an optical signal comprises measuring luminescence emission intensity.

Assignees

Inventors

Classifications

  • Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group · CPC title

  • C12Q1/34Primary

    involving hydrolase · CPC title

  • C07D501/24Primary

    with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3 · CPC title

  • with the 7-amino-radical acylated by an araliphatic carboxylic acid · CPC title

  • for tuberculosis · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9677112B2 cover?
β-Lactamase substrates and methods for using the substrates to detect β-lactamase diagnose tuberculosis.
Who is the assignee on this patent?
Texas A & M Univ Sys, Univ Leland Stanford Junior
What technology area does this patent fall under?
Primary CPC classification C12Q1/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).